James Edgemond
2019
In 2019, James Edgemond earned a total compensation of $16M as Chief Financial Officerand Treasurer at United Therapeutics, a 205% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $1,668,041 |
|---|---|
| Non-Equity Incentive Plan | $632,813 |
| Option Awards | $13,003,250 |
| Salary | $645,192 |
| Other | $19,600 |
| Total | $15,968,896 |
Edgemond received $13M in option awards, accounting for 81% of the total pay in 2019.
Edgemond also received $1.7M of change in pension value and nonqualified deferred compensation earnings, $632.8K in non-equity incentive plan, $645.2K in salary and $19.6K in other compensation.
Rankings
In 2019, James Edgemond's compensation ranked 298th out of 13,971 executives tracked by ExecPay. In other words, Edgemond earned more than 97.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 298 out of 13,971 | 98th |
Division Manufacturing | 102 out of 5,695 | 98th |
Major group Chemicals And Allied Products | 29 out of 2,194 | 99th |
Industry group Drugs | 24 out of 1,880 | 99th |
Industry Pharmaceutical Preparations | 20 out of 1,392 | 99th |
Source: SEC filing on April 29, 2022.
Edgemond's colleagues
We found three more compensation records of executives who worked with James Edgemond at United Therapeutics in 2019.